Charlotte Graafland, The Netherlands

  • Clinical (1)

    PB2.4: Onset-predictive biomarker testing for clinical trial recruitment in FTD: perspectives of (potential) mutation carriers

    Date: 20 Sep 2024Time: 09:42 - 09:45 CET